E-Abstract

JACC

Lots of interesting abstracts and cases were submitted for TCTAP 2023. Below are the accepted ones after a thorough review by our official reviewers. Don’t miss the opportunity to expand your knowledge and interact with authors as well as virtual participants by sharing your opinion in the comment section!

TCTAP A-087

External Validation of the SYNTAX Score II 2020: A Real-World Cohort Analysis From Asia

By Peizhi Wang, Jinqing Yuan

Presenter

Peizhi Wang

Authors

Peizhi Wang1, Jinqing Yuan1

Affiliation

Fuwai Hospital, China1
View Study Report
TCTAP A-087
Others (Unclassified)

External Validation of the SYNTAX Score II 2020: A Real-World Cohort Analysis From Asia

Peizhi Wang1, Jinqing Yuan1

Fuwai Hospital, China1

Background

The SYNTAX score II 2020 (SSII-2020) was developed to predict long-term major adverse cardiac and cerebrovascular events (MACE) following coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) in patients with 3-vessel disease(3VD). However, this novel score has not received sufficient evidence of external validation in real-world studies, especially in Asian individuals. The current study aimed to assess the ability of the SSII-2020 to predict treatment benefit of CABG vs PCI in a large cohort from China.

Methods

Five-year MACE was assessed in 2,250 patients with diabetes and 3VD enrolled in a Chinese PCI/CABG registry. Discrimination was assessed by Harrell’s C statistic, and calibration was assessed by calibration plots in the CABG and PCI arms, respectively. The ability of the SSII-2020 to predict treatment benefit of CABG vs PCI was assessed.

Results

Patients in the CABG subgroup were associated with a lower occurrence of 5-year MACE compared with those in PCI subgroup (12.0% vs 20.4%; log-rank P = 0.02). Both discrimination and calibration were helpful in the PCI arm (C-index: 0.72; slope: 0.95) but moderate in the CABG arm (C-index: 0.64; slope: 1.01). For 5-year MACE, the SSII-2020 could recommend a specific treatment with sufficient accuracy.

Conclusion

The SYNTAX score II 2020 for predicting 5-year MACE has the potential to support decision making on revascularization in Asian subjects with 3VD and diabetes. Further prospective external validations are warranted to validate our results.